Today in The Medium Newsletter, Anna Dorn shares stories by academics influenced by philosopher #HannahArendt: The Radical Politics of Joy by #philosophy professor Roger Berkowitz, and Speaking in Dark Times by sociologist Elisabeth Becker-Topkara.
Other featured stories discuss #DrugPricing in the U.S., #ProstateCancer testing (in the wake of the diagnosis of former president #JoeBiden), and the recent burning of the #NottowayPlantation in Louisiana.
https://blog.medium.com/joy-is-the-radical-belief-that-the-world-is-worthy-of-love-f81faa24e590
Annika Kim Constantino highlights President Trump's new executive order targeting U.S. prescription drug prices through a "most favored nation" policy. Unlike previous efforts, this broad approach aims to align costs with lower prices from other countries, but raises concerns about profitability and innovation in the pharmaceutical industry. Critics warn of potential legal battles and adverse market effects. Explore the details in the full article: https://www.cnbc.com/2025/05/12/trump-drug-pricing-order-most-favored-nation.html #DrugPricing #PharmaceuticalIndustry #TrumpAdministration #HealthcarePolicy #PrescriptionDrugs #MostFavoredNation
Tariffs on Pharmaceuticals May Be the Next Front in Trump’s War on Public Health
Trump and his commerce secretary are threatening to make medications more expensive by slapping tariffs on them.
Swedish drug agency’s new pricing model surprises, concerns patient and pharma groups https://www.euractiv.com/section/health-consumers/news/swedish-drug-agencys-new-pricing-model-surprises-concerns-patient-and-pharma-groups/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #drugpricing #EUPharmaPackage #Sweden
Making America sick again, trump revoked policies aimed at improving healthcare and shoring up pandemic resources.
#Healthcare
#TrumpKills #MAGAisEvil
#DrugPricing #VaccineAccess
#MakingAmericaSickAgain
Dutch trim medicines budget, but cause delayed access to new drugs, says pharma industry https://www.euractiv.com/section/health-consumers/news/dutch-reduced-spend-on-medicines-is-causing-delayed-access-to-new-drugs-says-pharma-industry/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #drugpricing #EUPharmaPackage #Netherlands
It is a glaring spotlight in which #obesity #DrugPricing is stuck. #Pharma will have to do better than saying it's tough luck if a person has bad insurance. Harsh inequities breed harsh feelings. @novonordisk is getting the wrong kind of attention.
https://conscienhealth.org/2024/08/obesity-drug-pricing-remains-stuck-in-the-spotlight/
Sweden favours compulsory application for medicines reimbursement in any member state requesting it [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/sweden-favours-compulsory-application-for-medicines-reimbursement-in-any-member-state-requesting-it/?utm_source=dlvr.it&utm_medium=mastodon #drugpricing #EUPharmaPackage #healthcare #Sweden
European Commission opens infringement procedures against Bulgaria over medicine tenders [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/european-commission-opens-infringement-procedures-against-bulgaria-over-medicine-tenders/?utm_source=dlvr.it&utm_medium=mastodon #Bulgaria #drugpricing #EUPharmaPackage
Breaking: Federal judge rules against two drugmakers' "freedom of speech" argument challenging #Medicare drug price negotiation program
https://www.statnews.com/2024/04/29/federal-judge-rules-against-two-drugmakers-challenging-medicare-drug-price-negotiation-program/ via @STAT
Amylyx to pull ALS drug Relyvrio From US, Canada markets after phase III fail—FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal—Novo Nordisk pushes back after price gouging accusations by Bernie Sanders--http://bit.ly/w28kSd #als #amylyx #relyvrio #ftc #bostonscientific #novonordisk #berniesanders #drugpricing #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Genmab leans into hot ADC space with $1.8B ProfoundBio acquisition—Medicare price negotiations carry on as HHS responds to Big Pharma's IRA counteroffers—More Americans forgoing ADHD meds as shortages drag on--http://bit.ly/w28kSd #mergersandacquisitions #genmab #adc #medicare #drugpricing #inflationreductionact #drugshortages #adhd #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Gilead bets on Xilio cancer drug as biotech restructures—Sanders blasts Novo Nordisk for ‘outrageous’ price of Ozempic, Wegovy—Boundless Bio breaks IPO lull with $100M fundraise--http://bit.ly/w28kSd #gileadsciences #solidtumors #berniesanders #drugpricing #novonordisk #ozempic #wegovy #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
"In a country defined by irrational, runaway drug spending, many gene therapies live on a rare island of semi-rationality: They cost a fortune, but the return, sometimes, is babies who get to have childhoods, grow up and become adults." 🥹
@STAT's Jason Mast on putting a price tag on a miracle...in a world where we already pay a lot of money for other drugs that demonstrably *don't* work:
https://www.statnews.com/2024/03/28/gene-therapy-mld-lenmeldy-orchard-price/
#health #healthcare #genetherapy #medicine #CRISPR #drugpricing #medmastodon
Viking touts promising phase I data for weight-loss pill candidate—At stake in mifepristone case: Abortion, FDA’s authority, and return to 1873 obscenity law—Insulin caps lowered costs but didn't improve access, study finds--http://bit.ly/w28kSd #vikingtherapeutics #clinicaltrials #weightloss #abortionpill #supremecourt #insulin #diabetes #drugpricing #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
BMS racks up phase III win in liver cancer targeted by AstraZeneca and Roche—J&J alleges ex-staffer downloaded thousands of files in move to Pfizer—Orchard sets new gene therapy price tag at $4.25M—the steepest of any drug in the US--http://bit.ly/w28kSd #bristolmyerssquibb #livercancer #roche #astrazeneca #jnj #pfizer #tradesecrets #genetherapy #drugpricing #orchardtherapeutics #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
National pharmacare must be protected from corporate interests
#Canada #Health #Politics #Pharmacare #HealthCare #CanadianDrugAgency #BillC64 #ConflictFree #PublicInterest #UniversalHealth #MedicationAccess #DrugPricing #PatientAdvocacy #HealthPolicy #Pharmaceutical
https://the-14.com/national-pharmacare-must-be-protected-from-corporate-interests/
Madrigal’s Rezdiffra energizes MASH Space, sets bar for future therapies—BMS, AstraZeneca, Novartis add to 2024 M&A upswing—AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers--http://bit.ly/w28kSd #mash #nash #liverdisease #novartis #bristolmyerssquibb #novartis #mergersandacquisitions #drugpricing #inhalers #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma